A
Alberto Levi
Publications - 7
Citations - 57
Alberto Levi is an academic researcher. The author has contributed to research in topics: Tuberculosis & Mycobacterium tuberculosis. The author has an hindex of 3, co-authored 6 publications receiving 26 citations.
Papers
More filters
Journal ArticleDOI
The IFNG rs1861494 Single Nucleotide Polymorphism Is Associated with Protection against Tuberculosis Disease in Argentina.
Agustín Rolandelli,Joaquín Miguel Pellegrini,Nicolás Oscar Amiano,Maria Cecilia Santilli,María Alicia Morelli,Florencia Andrea Castello,Nancy Liliana Tateosian,Alberto Levi,Nicolás Casco,Domingo Palmero,Verónica E. García +10 more
TL;DR: The findings indicate that the rs1861494 single nucleotide polymorphism (SNP) could be considered as a biomarker of tuberculosis resistance in the Argentinean population.
Journal ArticleDOI
Neutrophil autophagy during human active tuberculosis is modulated by SLAMF1
Joaquín Miguel Pellegrini,Florencia Sabbione,María Paula Morelli,Nancy Liliana Tateosian,Florencia Andrea Castello,Nicolás Oscar Amiano,Domingo Palmero,Alberto Levi,Lorena Ciallella,María Isabel Colombo,Analía Silvina Trevani,Verónica E. García +11 more
TL;DR: It is demonstrated for the first time that human neutrophils express SLAMF1 upon Mtb-stimulation and results indicate that SLAMf1 participates in neutrophil autophagy during active tuberculosis.
Journal ArticleDOI
Add-on inhaled budesonide in the treatment of hospitalised patients with COVID-19: a randomised clinical trial
Alvar Agusti,Gastón De Stefano,Alberto Levi,Xavier Muñoz,Christian Romero-Mesones,Oriol Sibila,Alejandra López-Giraldo,Vicente Plaza Moral,Elena Curto,Andrés L. Echazarreta,S. Márquez,Sergio Pascual-Guardia,Salud Santos,Alicia C Marin,Luis Valdés,Fernando Saldarini,Clara Salgado,Georgina Casanovas,Sara Varea,José Ríos,Rosa Faner +20 more
TL;DR: An investigator-initiated, open-label, randomised clinical trial (RCT) is designed to explore the efficacy of adding inhaled budesonide to usual care to prevent disease progression in patients hospitalised because of COVID-19 pneumonia.
Journal ArticleDOI
The Non-synonymous rs763780 Single-Nucleotide Polymorphism in IL17F Gene Is Associated With Susceptibility to Tuberculosis and Advanced Disease Severity in Argentina.
Agustín Rolandelli,Joaquín Miguel Pellegrini,Rodrigo Emanuel Hernández del Pino,Nancy Liliana Tateosian,Nicolás Oscar Amiano,María Paula Morelli,Florencia Andrea Castello,Nicolás Casco,Alberto Levi,Domingo Palmero,Verónica E. García +10 more
TL;DR: These findings identify the IL17F rs763780 SNP as a biomarker of tuberculosis susceptibility and advanced disease severity in Argentina, suggesting that IL 17F could be a critical cytokine in tuberculosis immunity.
Journal ArticleDOI
PGE2 displays immunosuppressive effects during human active tuberculosis.
Joaquín Miguel Pellegrini,Candela Martin,María Paula Morelli,Julieta Aylen Schander,Nancy Liliana Tateosian,Nicolás Oscar Amiano,Agustín Rolandelli,Domingo Palmero,Alberto Levi,Lorena Ciallella,María Isabel Colombo,Verónica E. García +11 more
TL;DR: It is demonstrated that PGE2 exerts a potent immunosuppressive action during the immune response of the human host against Mycobacterium tuberculosis (Mtb) infection and the potential of this lipid mediator as a tool to improve anti-TB treatment is highlighted.